摘要
肝癌死亡率高，其治疗始终是棘手的问题，长期以来缺乏有效的治疗措施，而机体的细胞免疫机制可以控制肝癌的发生发展．在其局部微环境中CD4＋CD25＋调节性T细胞（CD4＋CD25＋regulatoryTcells）和Th17在自身免疫耐受、移植和抗肿瘤应答中起着重要的作用，随着研究的进一步深入，将会对肿瘤的免疫治疗带来新的策略。
The treatment of liver cancer is very difficuh and the case fatality rate is very high. For a long time the lack of effective treatment measures. But the cellular immune mechanisms can control the development of liver cancer,CD4 ＋CD25 regulatory T and Thl7 cells have played important roles in the selfimmunotolerance,graft and antitumor response. With further research,it could provide a promising strategy for the treatment of liver cancer in elinic.
出处
《医学信息》
2012年第7期608-610,共3页
Journal of Medical Information
